Trang chủ › Ung thư dạ dày › Texas › Houston
Thử nghiệm lâm sàng cho Ung thư dạ dày tại Houston, TX
42 nghiên cứu cho Ung thư dạ dày đang tìm kiếm người tham gia tại các cơ sở ở Houston và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Đang tuyểnGiai đoạn 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Đang tuyểnGiai đoạn 2/3
- University of Texas MD Anderson Cancer Center, Houston
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Đang tuyểnGiai đoạn 2
- Research Site, Houston
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Đang tuyểnGiai đoạn 3
- MD Anderson Cancer Center, Houston
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Đang tuyểnGiai đoạn 2
- Research Site, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Đang tuyểnGiai đoạn 1/2
- MD Anderson, Houston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Đang tuyểnGiai đoạn 1
- Baylor College of Medicine, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Đang tuyểnGiai đoạn 1
- Oncology Consultants, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center - University of Texas, Houston
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Đang tuyểnGiai đoạn 3
- Research Site, Houston
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
Đang tuyểnGiai đoạn 1
- UT MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Research Site, Houston
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Oncology Consultants, Houston
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1
- Investigative Site #129, Houston
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas MD Anderson Cancer Center, Houston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Đang tuyểnGiai đoạn 2
- MD Anderson Cancer Center, Houston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- Oncology Consultants, PA, Houston
- Oncology Consultants, PA., Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Đang tuyểnGiai đoạn 3
- The University of Texas MD Anderson cancer Center, Houston
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Đang tuyểnGiai đoạn 1
- Baylor St. Luke's Medical Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Đang tuyểnNghiên cứu quan sát
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Comprehensive Outcomes for After Cancer Health
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
Thử nghiệm cho Ung thư dạ dày tại các thành phố khác
- Boston, MA32 nghiên cứu
- New York City, NY31 nghiên cứu
- Nashville, TN28 nghiên cứu
- Los Angeles, CA22 nghiên cứu
- Baldwin Park, CA22 nghiên cứu
- Arlington, VA20 nghiên cứu
- Dallas, TX19 nghiên cứu
- San Antonio, TX19 nghiên cứu
- Grand Rapids, MI18 nghiên cứu
- St. Louis, MO18 nghiên cứu
- Washington, DC16 nghiên cứu
- Detroit, MI16 nghiên cứu
Các nghiên cứu khác tại Houston
- Ung thư phổi không tế bào nhỏ145 nghiên cứu
- Ung thư vú126 nghiên cứu
- Ung thư (mọi loại)121 nghiên cứu
- Ung thư di căn104 nghiên cứu
- Ung thư đại trực tràng102 nghiên cứu
- Ung thư buồng trứng89 nghiên cứu
- Bạch cầu tủy cấp85 nghiên cứu
- Ung thư phổi78 nghiên cứu
- Ung thư tuyến tiền liệt76 nghiên cứu
- Ung thư nội mạc tử cung68 nghiên cứu
- Ung thư tụy61 nghiên cứu
- Ung thư hắc tố59 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 5 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.